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ARTICLE
Generalized Genomic Distance–Based Regression Methodology
for Multilocus Association Analysis
Jennifer Wessel and Nicholas J. Schork
Large-scale, multilocus genetic association studies require powerful and appropriate statistical-analysis tools that are
designed to relate genotype and haplotype information to phenotypes of interest. Many analysis approaches consider
relating allelic, haplotypic, or genotypic information to a trait through use of extensions of traditional analysis techniques,
such as contingency-table analysis, regression methods, and analysis-of-variance techniques. In this work, we consider
a complementary approach that involves the characterization and measurement of the similarity and dissimilarity of
the allelic composition of a set of individuals’ diploid genomes at multiple loci in the regions of interest. We describe a
regression method that can be used to relate variation in the measure of genomic dissimilarity (or “distance”) among a
set of individuals to variation in their trait values. Weighting factors associated with functional or evolutionary conser-
vation information of the loci can be used in the assessment of similarity. The proposed method is very ﬂexible and is
easily extended to complex multilocus-analysis settings involving covariates. In addition, the proposed method actually
encompasses both single-locus and haplotype-phylogeny analysis methods, which are two of the most widely used
approaches in genetic association analysis. We showcase the method with data described in the literature. Ultimately,
our method is appropriate for high-dimensional genomic data and anticipates an era when cost-effective exhaustiveDNA
sequence data can be obtained for a large number of individuals, over and above genotype information focused on a
few well-chosen loci.
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Modern genetics researchers have access to an unprece-
dented array of technologies and resources that can be
used to identify and characterize the inherited basis of
disease susceptibility. For example, the availability ofhigh-
throughput sequencing and genotyping technologies, the
information on the locations of ∼10 million SNPs in En-
sembl and related databases, and the recent release of al-
lele-frequency and linkage disequilibrium (LD) informa-
tion on 12 million SNPs by the International HapMap Proj-
ect investigators have provided researchers with resources
that should motivate them to pursue genetic association
studies of complex, multifactorial traits and diseases, such
as blood-pressure level and cancer. Unfortunately, the his-
tory of association studies that have been pursued to iden-
tify genetic variations that contribute to complex, multi-
factorial traits and diseases has been plagued by inconsis-
tent results,1 making it unclear how future large-scale as-
sociation studies that are based on the use of these re-
sources will fare. In general, the reasons for the lack of
replication among association studies of complex traits
and diseases are well recognized and reﬂect the simple fact
that the inﬂuence and identiﬁcation of each particular
gene or environmental factor inﬂuencing these traits and
diseases are often obscured or confounded by the effects
of other factors. More-speciﬁc reasons for a lack of repli-
cation include differences in the choice of polymorphic
sites to study, the genetic background of the population(s)
sampled, the deﬁnition of the phenotype used, and the
analysis methods used to assess associations.
Each of the issues plaguing association studies has been
dealt with in the literature, to some degree, and new strat-
egies are emerging that may strengthen conﬁdence in as-
sociation studies. For example, strategies for identifying
appropriate polymorphisms to consider in association stud-
ies have been described by researchers involved in the In-
ternational HapMap Project.2 These strategies are based on
the frequency of various alleles within and across popu-
lations, as well as the LD patterns that have emerged from
analyses of them.2 In addition, methodologies for both
uncovering and accommodating population-geneticback-
ground differences and potential cryptic substructurewith-
in a speciﬁc population are being developed, in an effort
to avoid false-positive and false-negative association-test
results attributable to the overall genetic heterogeneity of
populations.3,4 More-sophisticated phenotyping strategies
are also being developed, with an emphasis on assaying
subclinical endophenotypes that may more clearly reﬂect
pathophysiological perturbations associatedwith adisease
and that are inﬂuenced by inherited variations.5 The use
of these phenotyping technologies is likely to accelerate
the discovery of functionally relevant connections be-
tween particular genetic variations and subclinical pheno-
types of all sorts.
One of the thorniest problem areas for association stud-
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ies involves relating genotype information to phenotype
information in relevant statistical-analysis models. Al-
though many analysis models and tools have been pro-
posed in the literature, many of those tools either have
been developed as extensions of traditional statistical-anal-
ysis models, such as regression models, and, as such, have
inherited whatever limitations these traditional models
might have (e.g., assumptions of normality), or are rooted
in the exploitation of LD relationships between observed
marker-locus data and unobserved trait-inﬂuencing loci.
This focus on analysis methods that exploit LD is most
likely the result of the current expense of genotyping in-
dividuals at a large number of loci and, therefore, the need
to be economical in the choice of loci to study. We con-
sider a complementary data-analysis strategy for genetic
association studies that is based on the assessment and
analysis of the similarities and differences in the allelic
composition of individual genomes and the relationship
of these similarities/differences to phenotypic similarities/
differences. This strategy has been developed with ﬁve
phenomena—related to the human genome and human
physiology—in mind that, if ignored, could create prob-
lems for human association studies. We outline these ﬁve
phenomena below.
First, humans are diploid and, as such, the biological
effect of a gene or genes on phenotypic expression likely
involves the activities and actions of both gene copies
simultaneously (e.g., consider recessive-allele effects for
which two copies of the allele are needed to induce a
phenotype). In this light, analysis strategies that consider
merely the differences in the, for example, frequency of
haplotypes or alleles between individuals with and with-
out a phenotype may be ignoring biological realities of
the combined effects of the genes on the maternally and
paternally derived chromosomes each individual possesses.
The analysis of diplotypes, as opposed to haplotypes, how-
ever, is starting to receive attention among statistical ge-
neticists interested in association studies.6
Second, it is unlikely that individual variations observed
at different positions in a gene or within a group of genes
function in isolation. Rather, it is more likely that the net
effect of multiple variable sites in a gene or set of genes
inﬂuences phenotypic expression.7,8 Thus, there are likely
subtle (if not overt) interaction effects of multiple varia-
tions within a single gene on phenotypic expression that
can be observed only if one considers the inﬂuence of
these variations simultaneously in an analysis.
Third, the inheritance and the evolutionary history of
a set of gene variations may not be of direct relevance to
the phenotypic effect of those variations. Consider, for ex-
ample, the very contrived and somewhat improbable pos-
sibility that two chromosomes, each developing the same
set of de novo mutations that cause a phenotype, arose
in different locales at quite different times. In this situ-
ation, the assumption of a single haplotype surrounding
the causal allele would be inappropriate, andmethods that
exploit LD patterns and common haplotypesmay notwork
in this setting. Many analysis methods for association
studies that are designed to exploit LD seek to identify and
assign haplotypes and haplotype categories to individuals
on the basis of the ancestry of those haplotypes (i.e., the
origins of the chromosomes or haplotypes transmitted to
an individual from his or her parents and the relationships
of those haplotypes to a putative ancestral set of haplotypes
derived from a common ancestor). However, the actualmu-
tational or sequence proﬁle or combination of variations
in a gene and its regulatory elements are of greater relevance
to association studies than are the ancestry of those vari-
ations, and the real problem lies in identifying and sepa-
rating the functional variations from the neutral variations,
with respect to a particular phenotype.
Fourth, each individual is likely to have his or her own
unique genetic signature or combination of variations.
Consider the fact that the more polymorphic sites a re-
searcher considers in an association analysis, the greater
the likelihood that each individual in the study will pos-
sess a unique pattern of variations at those sites. Thus, it
is important to try to develop analysis methods for re-
ducing the number of contrasts to be made in an associa-
tion study by grouping individuals together on the basis
of the common or shared variations they possess.
Fifth, studies investigating the in vitro and in silico func-
tional signiﬁcance of genes and genetic variations are be-
ing pursued on a large scale. These studies can shed light
on polymorphic sites in the genome that are of direct
relevance to a particular trait or disease.9–11 In fact, a num-
ber of computational tools have been developed to help
distinguish variations of likely functional signiﬁcance on
the basis of, for example, amino acid changes in an en-
coded protein, position in a splice site of a gene, or posi-
tion in a transcription-factor binding site (TFBS).12–15
The association-analysis methodology that we describe
attempts to address these issues by taking a more holistic
multilocus diplotype view of the phenotypic effects of var-
iations within a gene7,16–18 and does not consider the an-
alysis of variations as single independent factors within
a gene. Our proposed association methodology considers
the relationship between variation in the similarity of the
allelic proﬁle (based on alleles at polymorphic loci) among
a group of individuals and additional information collected
about those individuals. In this light, our methodology
addresses questions such as: How much of the genomic
similarity assessed with respect to variations in a particular
genomic region exhibited by a group of individuals can
be explained by their disease statuses and relevant ancil-
lary information? Or, rather, is it the case that individuals
with a disease or elevated values of a particular phenotype
have similar genomes or genomic proﬁles in a region of
interest that is unlikely to have arisen by chance? The
method critically depends on measures of genomic sim-
ilarity and dissimilarity, or “distance.” Thesemeasures can
be constructed in such a way as to accommodate and/or
address the ﬁve aforementioned genomic and physiologic
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Figure 1. Heat-map representations of the similarity in the allelic proﬁles of 57 unrelated CEPH individuals based on variations in
the CHI3L2 gene (A) or the SQSTM1 gene (B), with use of a standard IBS allele-sharing measure. Note that individuals have been ordered
in the matrix by increasing CHI3L2 levels. The concentration of red cells in the matrix along the diagonal in panel A suggests an
association between similarity in CHI3L2 gene composition and CHI3L2 expression. The lack of a pattern in panel B suggests that no
association exists between similarity in SQSTM1 gene composition and CHI3L2 expression.
phenomena not often explicitly addressed in traditional
association-study data-analysis methodologies.
In describing the method, we consider the derivation
of different measures of genomic dissimilarity, or distance,
taking into account different features of genetic variations
for each measure. We then consider the derivation of a
test statistic that relates genomic dissimilarity to pheno-
typic end points (e.g., diagnosis, quantitative level of a
phenotype, etc.). Unlike other methods, our method does
not require clustering individuals into groups—which can
be problematic for a number of reasons, not the least of
which concerns the number of groups one should con-
sider as present in the data. In this light, our approach is
similar in orientation to the approach outlined in the
derivation of the analysis of molecular variance (AMOVA)
strategy of Excofﬁer et al.19 However, unlike the AMOVA
approach, the formulation of the model and test statistics
we use are more ﬂexible and can be used to assess multiple
phenotypes, covariates, and a priori populationgroupings,
as brieﬂy outlined in the “Subjects and Methods” section.
Our proposed method encompasses and can be used to
generalize single-locus and haplotype-phylogeny analysis
methods, in that one can pursue both single-locus analy-
ses and haplotype-phylogeny analyses with the proposed
procedure, as described in the “Subjects and Methods”
section. In this light, our method is at least as powerful
as those methods but provides possible extensions that
can accommodate settings and locus effects that tradi-
tional approaches cannot. Thus, our proposedmethod can
only improve traditional single-locus analysis of variance
(ANOVA) and haplotype-phylogeny analysis methods.We
describe data sets used to showcase the proposed tech-
niques and the results of relevant analyses of these data
sets. We end with a discussion and considerations of areas
for future research.
Subjects and Methods
Measures of Genomic Similarity
There are a number of strategies for characterizing the similarity
of individuals with respect to the variations they possess, both
within and across different genes. We describe seven example
methods for assessing the genomic similarity between two indi-
viduals on the basis of genotype data. Some of these methods
have been designed to accommodate weighting schemes for var-
ious factors, such as allele frequency or locus functional signiﬁ-
cance. In addition, it is possible that combinations of the ap-
proaches could be pursued (e.g., weighting by both frequency
and function). Weighted similarity measures have been exten-
sively studied in cluster-analysis contexts and so are appropriate
to consider in other contexts.20 Once a similarity measure has
been chosen, it can be evaluated for all pairs of N individuals in
a sample, to construct an similarity matrix, where elementN#N
i,j of that matrix contains the similarity value for individuals i
and j ( ). We note that other groups have consideredi,jp 1,…,N
different measures of genomic similarity that may be of value21
(see, e.g., the works by Mu¨ller et al.22 and by Sielinski23). We also
note that similarity matrices admit intuitive graphical represen-
tations in the form of heat maps and trees,24–26 which makes our
proposed analysis procedure intuitively appealing, as described
below (see also ﬁgs. 1 and 2).
Similarity based on identity-by-state (IBS) allele sharing.—The frac-
tion of alleles that any two individuals share purely by state (e.g.,
the two individuals possess the same allele or variant at a locus)
can be calculated easily enough. Since humans have two copies
of each position on the genome, it is simple to determine how
many alleles (0, 1, or 2) a pair of individuals shares. By dividing
by twice the number of loci or positions studied, one can obtain
an estimate of the fraction of alleles shared IBS by those individ-
uals. Pairwise similarities derived in this manner have been used
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Figure 2. Tree representation of the similarity in the allelic pro-
ﬁles of 57 unrelated CEPH individuals. The legend is available in
its entirety in the online edition of The American Journal of Human
Genetics.
Figure 3. A, Tree representation of the phylogenetic relationships of haplotypes derived from the CHI3L2 genotype data for the 57
unrelated CEPH individuals, with use of the method of Seltman et al.35,38 B, The distance matrix used to construct the phylogenetic
tree, with the numbers on the rows and columns identifying the different haplotypes. Note that the haplotypes are identiﬁed with
numbers assigned arbitrarily (C). Haplotypes that are phenotypically similar are denoted by their corresponding symbols.
to construct a matrix for cluster (and related) analyses, to address
population genetic research questions.27,28 The IBS-sharing simi-
larity, , can be calculated for individuals i and j ( )S i,j,p 1,…,Ni,j
with the formula
L
l l l s (g ,g )i,j i j
lp1IBSS p , (1)i,j 2L
where L is the number of loci considered in the calculation; lgi
and are the genotypes of individuals i and j, respectively, at thelgj
lth locus ( ); and is a function mapping the ge-l l llp 1,…,L s (g ,g )i,j i j
notype information, for individuals i and j at locus l, to a partic-
ular numeric value and, for our purposes, has a value of 0.0 if
individuals i and j are homozygous for different SNP alleles (e.g.,
and ), a value of 1.0 if they share one allele (e.g.,l lg p AA g p TTi j
and ), and a value of 2.0 if they share both allelesl lg p AA g p ATi j
(e.g., and )—note that we are assuming, through-l lg p AA g p AAi j
out, that interest is in SNP loci with two alleles, as opposed to
microsatellite markers and other forms of genetic variation, al-
though the proposed method can be easily extended to cover
situations in which those forms of variation are examined.
Similarity based on weighting by allele frequency.—Allele-frequency
information can be included in the construction of the measure
of similarity. The intuition behind the accommodation of allele
frequency is that individuals who share rare allelesmay havemore-
similar genomes than do individuals who share common alleles
(i.e., since many people will have common alleles, individuals
possessing them are not easily distinguished from others). Lynch
and Ritland devised a method (hereafter called “the LR method”)
for assessing genomic similarity, on the basis of genotype data,
that accounts for allele frequency and has been shown to have
some favorable properties for identifying population subgroups.21,
29,30 With notation derived from equation (1), weighted similarity
measures can be computed easily as
L
l l l l ws (g ,g )i,j i j
lp1wS p , (2)Li,j
l w
lp1
where is a positive number reﬂecting the weight assigned tolw
locus l.
IBS allele sharing, with weighting for functionality of variations.—One
can accommodate knowledge of the “functional signiﬁcance” of
variations in a measure of genomic similarity by giving greater
weight in the sharing measure to loci harboring functional var-
iations. These weights must be determined a priori and can be
based on, for example, the results of cellular in vitro assays in-
vestigating the inﬂuence of variations on gene expression or pro-
tein-binding potential. As an example, consider a situation in
which in vitro functional-analysis assays suggest that variations
at two polymorphic sites in the promoter region of a gene resulted
in a 1.5-fold and a 2.0-fold increase in expression levels and that
a variation at another polymorphic site resulted in a protein amino
acid change that causes a binding site in that protein to induce
a 2.0-fold increase in activity of the protein. In this hypothetical
situation, one could assign weights of 1.5, 2.0, and 2.0, respec-
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tively, to the loci harboring these variations, in the construction
of the similarity measure.
Similarity based on weighting by nucleotide conservation across spe-
cies.—In the absence of data on the potential functional effect of
variations, one could consider a criterion for weighting loci in a
genomic similarity measure that is based on conservation of nu-
cleotides across species. It has been argued that nucleotides that
are conserved throughout evolution are more likely to be of func-
tional signiﬁcance, since changes at those positions may have
undergone negative selection; see, for example, the works of Shah
et al.,31 Frazer et al.,32 and Brudno et al.33 Thus, one could weight
genomic positions used in a genotype-based similarity measure
by the degree of evolutionary conservation at those positions.
Similarity based on single-locus–analysis results.—We consider the
use of single-locus–analysis results in the construction of a mul-
tilocus similarity measure. Single-locus analyses can be pursued
before the construction of a similarity measure or could be based
on analyses performed previously with another data set. We con-
sider the use of the negative log of the P value associated with
single-locus–analysis test statistics as weights in the construction
of a similarity measure using, for example, equation (2) or equa-
tion (3).
Unweighted and weighted haplotype-pair similarity.—By phasing in-
dividuals (i.e., assigning them haplotypes that reﬂect variations
they inherited on their maternally and paternally derived chro-
mosomes), one can assess the similarity of two individuals’ chro-
mosome pairs. A relevant similarity measure would depend crit-
ically on how one pairs (or matches) the chromosomes between
the two individuals, since the similarity could be very different
for the two possible pairings. A better measure would involve
computing the similarity with the assumption of both pairings
and then taking the maximum measure that results from these
two pairings as the measure of similarity. Consider, for example,
the simple situation in which individual a has haplotypes ha1p0-
0-0-0 and ha2p1-1-1-1 and individual b has haplotypes hb1p1-
1-1-1 and hb2p0-0-0-0. Then, to assess haplotype similarity, if
one pairs ha1 with hb1 and pairs ha2 with hb2, the individuals
would have completely different genomes (i.e., have maximal
distance, or zero similarity). However, if one pairs ha1 with hb2
and pairs ha2 with hb1, then the individuals have identical ge-
nomes. We believe that use of the pairing that maximizes the
similarity is appropriate, and that was the motivation for the
measure reﬂected in equation (3). Haplotype-based sharing can
easily accommodate weighting schemes based on, for exam-
ple, conservation or functionality, in which some loci have
been weighted because of their putative functionality. Although
slightly more complicated than the genotype similarity–based
measures, haplotype pair–similarity measures can be computed
as
L
h l l l l l l lS pmax w [s (h ,h ) s (h ,h )],i,j i,j i,1 j,1 i,j i,2 j,2{
lp1
L
l l l l l l lw [s (h ,h ) s (h ,h )] i,j i,1 j,2 i,j i,2 j,1 }
lp1
1
L
l# w , (3)( )
lp1
where the similarity function considers the alleles on speciﬁc
haplotypes possessed by individuals i and j and would assign a
numerical value of 0.0 if the individuals did not have the same
allele on those haplotypes and 1.0 if they did (note that, in eq.
[3], refers to individual i’s allele at position l of his or herlhi,1
chromosome designated as 1, as opposed to 2). In addition, the
fact that one could pair the ﬁrst haplotype (arbitrarily deﬁned)
possessed by individual i with either the ﬁrst or the second hap-
lotype possessed by individual j is accommodated in the calcula-
tion by use of the maximum of these two pairings to deﬁne the
similarity.
Similarity based on ancestry.—There are many association-anal-
ysis methods that consider similarity in the phylogenetic con-
nections or ancestry of haplotypes.34–37 For example, the programs
eHAP,35,38 HAP,39 Arlequin,40 and GeneTree41 produce phylogenies
of chromosomes on the basis of genotype data. The phylogenies
produced by these programs can then be used to group individ-
uals into smaller subgroups that can be used to contrast pheno-
typic features. We consider this approach as an alternative to
those that are based on, for example, functional-variation simi-
larity, although recent studies have suggested that grouping hap-
lotypes on the basis of phylogeny and then contrasting the re-
sulting groupings for phenotypic differences does not substan-
tially increase power to detect an effect (see, e.g., the work of
Humphreys and Iles42 and Bardel et al.43). However, we note that
one can exploit ancestral relationships between haplotypes to
derive a similarity measure. Essentially, from a phylogenetic tree,
one can determine the distance between haplotypes (e.g., on the
basis of the number of mutations, recombinations, gene conver-
sions, or transitions that must have occurred to derive one hap-
lotype from another ancestral haplotype) (see ﬁg. 3). With this
information, one can pair the haplotypes that two individuals
possess and can compute the phylogenetic distance between
those haplotypes. Since this pairing can occur in two ways, we
take the pairing that produces the minimum distance between
the two individuals as reﬂecting the similarity between them, as
was done for the haplotyping pairing–similarity measures dis-
cussed above.
Regression-Based Distance Matrix Analysis
Once one has computed a similarity matrix, that matrix can be
subjected to a regression analysis that tests hypotheses about
whether variation in the level of similarity exhibited by pairs of
individuals reﬂected in that matrix can be explained by other
features those individuals possess (e.g., whether they possess a
certain phenotype or have higher or lower values of a particular
quantitative phenotype). To describe the regression model, we
consider an analysis involving a gene or genomic region that
harbors L different polymorphic loci. We also assume that each
of N individuals or study subjects has been genotyped at these L
loci. We assume also that M phenotypic variables have been col-
lected on the N subjects. These phenotypic variables could in-
clude information about the presence or absence of a disease end
point (e.g., coded using dummy variables, such as 0 assigned
to individuals without the disease and 1 assigned to individuals
with the disease); disease-associated quantitative variables, such
as blood pressure and cholesterol level; and important covariates,
such as age, sex. smoking status, etc. We assume that interest is
in relating the disease end points or quantitative variables to the
genomic proﬁles of the individuals, as captured by the genotypic
information collected about them.
Construct an similarity matrix with, for example, oneN#N
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of the measures described in the “Measures of Genomic Similar-
ity” section. Transform the matrix into a dissimilarity, or “dis-
tance,” matrix by, for example, subtracting the components of
the matrix from 1.0 if the IBS measure is used or by subtracting
them from 1.0 after each component in the matrix is divided by
the theoretical or empirical maximum of the similarity measure,
to scale the entries to lie between 0 and 1. We note that the
proposed regression procedure does not require that the distance
matrix have metric properties.44 Let this distance matrix and its
elements be denoted by ( ), for the N subjects.Dp d i,jp 1,…,Nij
The possibility that will not pose problems in the proposedN K L
regression-analysis setting. Let X be an matrix harboringN#M
information on the M phenotypic variables that will be modeled
as predictor or regressor variables whose relationships to the val-
ues in the genomic similarity matrix are of interest. Compute the
standard projection matrix, , typically used to es-′ 1 ′Hp X(XX) X
timate coefﬁcients relating the predictor variables to outcome var-
iables in multiple-regression contexts. Next, compute the matrix
1 2Ap (a )p ( d ) ,ij ij2
center this matrix with use of the transformation discussed by
Gower,45 and denote this “matrix G” as
1 1′ ′Gp I 11 A I 11 .( ) ( )n n
An F statistic can be constructed to test the hypothesis that the
M regressor variables have neither relationship to variation in the
genomic distance nor dissimilarity of the N subjects reﬂected in
the distance/dissimilarity matrix as done by McArdle andN#N
Anderson46:
tr(HGH)
Fp . (4)
tr[(IH)G(IH)]
If the Euclidean distance is used to construct the distance matrix
on a single quantitative variable (i.e., as in a univariate analysis
of that variable) and appropriate numerator and denominator
degrees of freedom are accommodated in the test statistics, then
the F statistic in equation (4) is equivalent to the standardANOVA
F statistic.46 The distributional properties of the F statistic are
complicated for alternative distance measures computed formore
than one variable, especially if those variables are discrete, as in
genotype data. However, permutation tests can then be used to
assess statistical signiﬁcance of the pseudo–F statistic.44,46–50 The
M regressor variables can be tested individually or in a stepwise
manner.
Graphic Display of Similarity Matrices
Similarity matrices of the type we describe can be represented
graphically in a number of ways that can facilitate interpretation.
We consider heat-map and coded-tree (or dendogram) represen-
tations.24–26 Heat maps simply color code the elements of a sim-
ilarity matrix, such that higher similarity values are represented
as “hotter,” or redder colors, and lower similarity values are rep-
resented as “colder,” or bluer colors. If the matrix is ordered such
that individuals with similar phenotype values are next to each
other, then neighboring cells along the diagonal of the matrix
(representing individuals with similar phenotype values) will
present patches of red, indicating a relationship between the phe-
notype values and similarity (ﬁg. 1A and 1B). Trees are con-
structed such that individuals with greater genomic similarity are
placed next to each other (i.e., they are represented as adjacent
branches of the tree). Less similar individuals are represented as
branches some distance away from each other. By color coding
the individual branches on the basis of the phenotype values of
the individuals they represent, one can see if there are patches
of a certain color on neighboring branches, which would indicate
that phenotype values cluster along with genetic similarity (ﬁg.
2)
The CEPH Family Gene-Expression Data as an Example
Data Set
To showcase the proposed method relative to other methods, we
considered an analysis involving gene-expression and SNP data
collected on 57 unrelated CEPH individuals. These individuals
were chosen by HapMap researchers for massive, genomewide
genotyping studies2 and were also used to assess gene-expression
patterns obtained from immortalized lymphocytes51 (Gene Ex-
pression Omnibus accession number GSE2552). Our analysis ex-
cluded individual NA06993 in the gene-expression studies, be-
cause detailed analysis of HapMap data suggested that the sample
associated with this person is likely to have derived from an un-
reported relative. We also added data associated with individual
NA12056, since gene-expression data for this individual is now
available. We focused on the analysis of variations genotyped on
the CEPH individuals in the CHI3L2 gene (MIM 601526), since
Cheung et al.51 found very compelling evidence of association
and linkage to this gene for the expression levels of the CHI3L2
gene, reﬂecting likely cis-acting sequence variations inﬂuencing
expression of the encoded protein. We downloaded, from the
HapMap database, data on 43 SNPs in the CHI3L2 gene that were
genotyped on the 57 CEPH individuals with CHI3L2 gene–ex-
pression values (chromosome 1: 111069007–111084786;Ensembl
position 111482322–111498101). We derived the positions of the
SNPs from the latest version of the human physicalmap provided
in Ensembl. We note that these positions disagree slightly with
those reported by Cheung et al.51
Haplotyping and Basic Analysis of the Expression Data
Haplotypes and diplotypes (i.e., the pairs of haplotypes each in-
dividual possesses) were inferred using HAP.39 Repeated, multiple
gene–expression values collected for each of theCEPH individuals
were averaged, when available. We considered use of log2-trans-
formed expression levels because of skewness in the expression
values. We assessed the association between the SNPs in the
CHI3L2 gene and CHI3L2 gene–expression values, using regres-
sion analysis of each, coded as 0, 1, or 2, depending on how
many minor alleles each individual possessed at a SNP locus. We
also tested for haplotype associations, using the haplotype-phy-
logeny–analysis methods described by Seltman et al.35,38 We then
applied the proposed analysis method using different similarity
measures. We also included analyses that considered each locus
in isolation, using the proposed similarity-regressionprocedure—
that is, we constructed the similarity matrix using genotype in-
formation for each locus independently. To correct for multiple
testing in the single-locus analyses, we used the method devel-
oped by Nyholt,52 to determine the “effective” number of inde-
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Table 1. Resources for Identifying or Predicting Function and Conservation in CHI3L2
Reference Function Comment
Cheung et al.51 In vitro Twofold increased binding of RNA polymerase II (TrG allele)
PupasView Comprehensive
SIFT Nonsynonomous SNPs Sorting Intolerant from Tolerant
PolyPhen Nonsynonomous SNPs
ESEﬁnder ESEs
RESCUE-ESE ESEs
Gene Regulation TFBSs For P-Match
Vista Tools TFBSs For rVISTA
UTRScan UTR functional elements
ITB Blast UTR functional elements For BigBlast
VISTA Genome Browser Conservation
PipMaker and MultiPipMaker Conservation For PipMaker
pendent SNPs from the total of 26 that we studied. The effective
number of independent SNPs was found to be ∼14. We then used
a Sidak-corrected P value to declare signiﬁcance at the nominal
level of . For the distance-based regression analysis,weusedP ! .05
100,000 permutations of the data to assess the probability of a
type I error. We considered sex as a covariate in the analysismeth-
ods used.
Assessing SNP Functional Signiﬁcance for Similarity-Measure
Weighting
For the proposed similarity measure exploiting functional infor-
mation on the SNPs, we considered the use of a number of re-
sources, including results of in vitro studies, (e.g., promoter-re-
porter cell transfection and/or model species analyses), in silico
(computational) structure and sequence analysis, and sequence-
conservation analyses. We considered SNPs in all the genetic
regions that were available—for example, putative functionally
relevant SNPs, such as coding (synonymous and nonsynonymous)
and noncoding (exonic splicing enhancers [ESEs] and TFBSs, in
both the 5′ and 3′ UTRs), as well as likely neutral variations, such
as SNPs in functionally obscure intronic sites. We used available
Web-based tools and programs to assess functionality (see table
1, which describes the analysis tools and references for our as-
sessment of functionality and conservation). To complement the
information we obtained from individual Web sites, we used
PupasView, a Web site that gives comprehensive functional in-
formation from many individual programs and databases. To as-
sess evidence of evolutionary sequence conservation at the site
harboring each SNP, we leveraged data from multiple species.
Genomic regions that show evidence of multiple-species se-
quence conservation at the nucleotide level are more likely to
have undergone selective pressures and, hence, are likely to be
of functional signiﬁcance.53 Use of multiple-species genomes in
comparisons with the human sequence (as the reference genome)
has the advantage of providing stricter criteria, which minimizes
false-positive conservation results with any one species and im-
proves the ability to classify elements as actively conserved be-
cause of functional consequences rather than shared ancestry. For
weighting based on sequence conservation, sites had to be iden-
tiﬁed as conserved in two or more species to be given a greater
weight; when sites were found conserved across more than two
species, more weight was given. In using functional informa-
tion to weight the SNPs in a similarity measure, we intentionally
kept our weighting scheme simple so as not emphasize the ab-
solute value of the weight; rather, the weighting was relative
to each SNP. We felt that the most weight should be given to
SNPs characterized as functional by in vitro methods (e.g., SNP
) (see table 2). If multiple in silico methods iden-rs755467p 2.0
tiﬁed a SNP as having plausible functional consequence, then
more weight was given to that SNP than to those for which only
one method suggested functionality. In addition, because of im-
precision in the computational identiﬁcation of regulatory bind-
ingmotifs, we required agreement among programs used for iden-
tifying a sequence as being in a TFBS, a UTR, or an ESE, to reduce
false-positive results.
Results
Polymorphic Variation in CHI3L2
In CHI3L2, 11 SNPs were monomorphic, and 6 SNPs were
excluded because of low minor-allele frequency (!2.0%)
(data not shown). Five SNPs were not in Hardy-Weinberg
equilibrium (HWE) ( ) (table 2). Because of the thor-P ! .05
ough quality assessment and control of the data by the
HapMap researchers, we assumed that those SNPs not ex-
hibiting HWE were not an artifact of genotyping; there-
fore, we opted to keep them in the analyses but also con-
ducted analyses that excluded those SNPs. Four SNPs were
tagging SNPs (tSNPs), on the basis of HapMap analyses.
Five SNPs in the CHI3L2 gene were coding SNPs, as re-
ported to dbSNP, one of which was genotyped by the
HapMap researchers. The other SNPs were in noncoding
or regulatory regions. The majority of the SNPs were in
strong LD (average ), with the exception of SNP′D p 0.97
Thr313Thr, which showed weaker LD ( )′D p 0.02–0.80
with nine other SNPs (data not shown but easily visualized
on the HapMap site).
SNP Functionality and Sequence Conservation Assessment
Results
In Vitro and In Silico Analysis of CHI3L2 Variation.—Promoter
activity of luciferase reporter assays containing the rs755467
SNP was twofold higher (TrG allele) than that of con-
structs not containing the rs755467 SNP. This increase in
promoter activity was because of stronger binding of RNA
polymerase II.51 Four SNPs were identiﬁed, through in silico
methods, as being in potential ESE sites (table 2). Although
analyses involving the Web site PupasView found results
Table 2. Characteristics of CHI3L2 SNPs, Functional Consequences, and Conservation
SNP
Ensembl
Position Location
Minor-
Allele
Frequency HWE P tSNP ESEﬁndera RESCUE-ESEa
Functional
Weight Frog Chicken Mouse Cow Opossum Dog Fugu Chimpanzeeb
Conservation
Weight
rs755467c 111482465 Intron 1 .28 .739 N Y (1) 2 62 99 1.15
rs2147790 111482633 Intron 1 .16 .082 N 1 62 99 1.15
rs2255089 111485610 Intron 3 .46 .253 N Y (1) 1 34 63 20 18 97 1.30
rs2274232 111485642 Intron 3 .11 .003 N Y (1) 1 34 63 63 20 18 97 1.45
rs2147789 111485872 Intron 3 .44 .025 Y Y (3) 1 34 63 29 100 1.25
rs2182115 111486179 Intron 4 .09 .011 N Y (2) 1 26 33 64 28 98 1.30
rs1325284 111487834 Intron 4 .33 1.000 N Y (1) Y (3) 1.5 70 28 98 1.65
rs2251715 111490229 Intron 5 .44 .274 N 1 72 35 98 1.50
rs961364d 111490510 Intron 6 .26 .613 N Y (1) Y (1) 1.75 19 19 71 42 31 99 1.70
rs2764543 111491140 Intron 7 .31 .771 N 1 68 98 1.15
rs7366568 111491806 Intron 7 .25 .020 N Y (4) 1 24 98 1.10
rs2820087 111492376 Intron 7 .28 .975 N Y (2) 1 37 98 1.10
rs6685226 111492646 Intron 7 .17 .142 N Y (1) 1 51 70 98 1.35
rs11583210 111493928 Intron 8 .25 .075 Y 1 29 30 73 28 25 98 1.60
rs12032329 111494414 Intron 8 .12 .003 N Y (2) 1 29 30 71 98 1.55
rs2477578 111495313 Intron 8 .33 1.000 N Y (1) 1 29 71 13 98 1.55
rs2494006 111495483 Intron 8 .28 .956 N Y (2) 1 29 71 98 1.50
rs7542034e 111496023 Thr313Thr .02 .888 N Y (3) 1.35 60 62 88 79 61 97 1.75
rs942694 111496180 Intron 9 .33 1.000 N 1 30 16 52 25 98 1.30
rs942693 111496200 Intron 9 .33 1.000 N Y (2) 1 30 16 52 25 98 1.30
rs2182114 111496269 Intron 9 .33 1.000 N Y (1) 1 30 16 52 98 1.40
rs5003369 111496447 Intron 9 .33 1.000 Y Y (1) 1 30 52 98 1.20
rs11102221 111496858 Intron 9 .26 .161 N Y (1) 1 30 71 38 98 1.55
rs3934922 111497436 Intron 10 .30 .556 Y Y (3) Y (2) 1.25 34 72 99 1.50
rs3934923 111497509 Intron 10 .33 1.000 N Y (1) 1 34 72 99 1.65
rs8535 111497971 Exon 10 .28 .739 N Y (1) 1 32 64 100 1.20
NOTE.—In silico results from UTR, TFBS, and nonsynonomous SNPs are omitted, since no functional SNPs were identiﬁed. Twelve species were considered in VISTA Genome Browser, ﬁve with
high conservation (170% identity). Fifteen species were considered in PipMaker; Drosophila results from PipMaker were omitted (62% conservation at rs7542034).
a The number of sequence motifs identiﬁed by the ESEﬁnder and RESCUE-ESE programs is shown in parentheses.
b Chimpanzee results are combined from VISTA Genome Browser and PipMaker.
c In vitro results showed 2 times greater binding by RNA polymerase II to the T allele, compared with the G allele.
d PupasView ﬁnding was a triplex, a possible regulatory element.
e PupasView ﬁnding was an ESE (3).
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similar to the analysis results based on other Web-based
tools, it also uniquely identiﬁed a triplex, a possible reg-
ulatory element. UTRScan and BIGBlast did not identify
any SNPs in UTR-binding motifs, and, similarly, P-Match
(Gene Regulation) and rVISTA (Vista Tools) did not iden-
tify any TFBSs (results not shown). There were no non-
synonomous SNPs for evaluation.
Sequence Conservation Analysis of CHI3L2 Variation.—VISTA
browser2 (VISTA Genome Browser) was used to com-
pare the sequence ofCHI3L2 (chromosome 1: 111482202–
111498000) from human (reference genome, May 2004
build, except that the chimpanzee sequence was com-
pared with the July 2003 build) with 10 other available
species. Overall, the amount of highly conserved sequence
decreasedwith increasing phylogeneticdistance.Chimpan-
zee, cow, dog, opossum, and fugu exhibited some highly
conserved regions with humans; chimpanzee had the larg-
est number of conserved sequences, and fugu had the least
(170% identity) (note that fugu has conserved sequence
but does not contain any of the SNPs investigated in the
present study). When we reduced to 5% the allowable
percentage of identity for analysis, there was moderate
conservation with mouse, frog, and chicken, and there
was no conservation with rat or zebra ﬁsh. PipMaker and
MultiPipmaker were also used for pairwise and multiple-
species comparisons and to extend to different species
not available at the VISTA Genome Browser Web site.
PipMaker and VISTA Genome Browser pairwise compari-
sons gave slightly different results because of the different
algorithms used (local vs. global homology, respectively).
Only VISTAGenome Browser results are shown.Nine SNPs
were in highly conserved regions in two or more species,
whereas some conservation was found with other species
(table 2). For comparisons involving a species more evo-
lutionarily distant from humans, we studied sequence
fromDrosophila melanogaster.We found that only one SNP,
Thr313Thr—the SNP that was most consistently con-
served across multiple species—was in a conserved region,
which suggests itmight be a functionally important region
for this gene. Anopheles gambiae was compared with hu-
man, and no conserved sequences were identiﬁed (data
not shown). Comparison across multiple species, which
can identify conserved regions possibly under selection,
revealed SNPs with sequences conserved across multiple
species and with more-distant species (rs7542034 and
rs2255089).
To assign weights that were based on this information,
we used a minimum identity of 70% to locate SNPs that
were in highly conserved regions. Then, we lowered the
minimum threshold to 5%, to identify regions of mod-
erate conservation (40%–69%) or low conservation (10%–
39%). Under the assumption that the in vitro results give
the most-compelling results, our conservation weighting
was scaled from 1 to 1.75, where 1 is no conservation across
multiple, pairwise species comparisons and 1.75 is the
most conserved region (with high conservation and the
most species) and represents a value less than those of the
in vivo results. We categorized conservation levels as high,
moderate, or low and used this scheme to assign weights
to the loci. We recognize that our scheme for assigning
weights may seem arbitrary, but we chose to expose the
use of weights that are based on different criteria and
not necessarily to focus on the optimal manner in which
weights can be assigned.
Single Locus–Analysis Results
Of the 26 SNPs, 14 were signiﬁcantly (i.e., ) asso-P .001
ciated with CHI3L2 log2-transformed expression levels af-
ter correction for multiple tests (note that none of these
analyzed SNPs deviated from HWE) (table 3 [columns 3–
6]). In addition, two of the four SNPs identiﬁed as tSNPs,
according to the HapMap Web site, were signiﬁcantly as-
sociated with CHI3L2 levels. We also include in table 3
the results of the single-locus analyses with use of the
proposed similarity-analysis approach (columns7–10), and,
as can be seen, the single-locus results with the proposed
procedure correspond well with results obtained from the
traditional regression-based single-locus analysis. We note
that the Spearman rank correlation between the P values
obtained from these two analyses was 0.862 ( ).P ! .0001
Thus, our proposed procedure can be used to conduct sin-
gle-locus analyses.
Haplotype Associations and Haplotype-Phylogeny Results
We analyzed the data, using eHAP, a program that infers
haplotypes and implements evolutionary-based associa-
tion analyses (ﬁg. 3A). eHAP constructs a cladogram that
is based on the method described by Templeton et al.34
and then performs sequential association testing between
“nearby” haplotype clades, collapsing them and grouping
them together if no trait differences are found between
the two haplotype groups, given the others. Because of
algorithmic limitations, redundant SNPs ( ) were′D p 1.0
deleted by choosing the least informative (no function-
ality) SNPs to represent a group. Eight common haplotypes
consisting of 13 SNPs were identiﬁed with frequencies
of 1.5%–30.3% (ﬁg. 3C). The ﬁnal grouping that showed
the maximum phenotypic difference in CHI3L2-expres-
sion levels consisted of haplotypes 6 and 7 versus haplo-
types 1–5 and 8 ( ). This latter grouping containsPp .0009
the minor alleles of the two most functionally important
SNPs (rs755467 and rs7542034) that have in vitro and
strong conservation evidence. The distance matrix calcu-
lated as part of the analysis implemented in the eHAP
program (ﬁg. 3B) was also used to construct a measure of
similarity between individuals.
Similarity Regression-Analysis Results
Analysis of multiple loci in CHI3L2.—Signiﬁcant associa-
tions between the values in the genomic-similaritymatrix
and gene-expression levels were found with each of the
measures of genetic similarity (table 4) ( ). Most no-P ! .001
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Table 3. Individual SNP Associations with CHI3L2 Expression Levels
SNP Location
Traditional Regression Analysis
()log10 P
Similarity Regression Analysis
F Exact P Corrected Pa
Variation
(%) IBS F IBS P
Variation
(%)
rs755467 Intron 1 15.57 64.58# 10 .00006 37 4.19 3.71 .00001 36
rs2147790 Intron 1 .28 17.53# 10 1.00000 1 .00 .17 .68502 00
rs2255089 Intron 3 3.68 23.16# 10 .36208 12 .44 6.49 .01408 11
rs2274232 Intron 3 1.01 13.70# 10 .99845 4 .00 2.01 .16097 4
rs2147789 Intron 3 5.44 37.70# 10 .10257 19 .99 8.66 .00477 16
rs2182115 Intron 4 2.23 11.17# 10 .82511 8 .08 4.50 .03784 8
rs1325284 Intron 4 16.85 62.06# 10 .00003 38 4.54 19.97 .00008 27
rs2251715 Intron 5 3.28 24.52# 10 .47667 11 .32 6.38 .01496 10
rs961364 Intron 6 15.37 66.94# 10 .00010 39 4.01 31.38 .00001 39
rs2764543 Intron 7 12.99 52.57# 10 .00036 33 3.44 15.59 .00025 22
rs7366568 Intron 7 1.35 12.51# 10 .98254 3 .01 1.35 .25222 3
rs2820087 Intron 7 1.86 41.00# 10 .00140 31 2.85 15.23 .00023 23
rs6685226 Intron 7 .41 16.69# 10 1.00000 2 .00 .42 .51809 1
rs11583210 Intron 8 1.44 12.45# 10 .98048 5 .01 2.66 .10922 5
rs12032329 Intron 8 .89 14.15# 10 .99945 3 .00 1.79 .18856 3
rs2477578 Intron 8 16.85 62.06# 10 .00003 38 4.54 19.97 .00008 27
rs2494006 Intron 8 15.26 67.82# 10 .00011 39 3.96 14.12 .00046 23
rs7542034 Thr313Thr .00 19.66# 10 1.00000 0 .00 .00 .96759 0
rs942694 Intron 9 16.99 62.22# 10 .00003 40 4.51 2.08 .00006 28
rs942693 Intron 9 16.85 62.06# 10 .00003 38 4.54 19.97 .00008 27
rs2182114 Intron 9 16.85 62.06# 10 .00003 38 4.54 19.97 .00008 27
rs5003369 Intron 9 16.85 62.06# 10 .00003 38 4.54 19.97 .00008 27
rs11102221 Intron 9 1.39 12.57# 10 .98432 5 .01 2.56 .11535 4
rs3934922 Intron 10 13.45 51.82# 10 .00025 33 3.59 26.96 .00001 33
rs3934923 Intron 10 16.85 62.06# 10 .00003 38 4.54 19.97 .00008 27
rs8535 Exon 10 15.57 64.58# 10 .00006 37 4.19 3.71 .00001 36
NOTE.—Association analysis with averaged, log2 gene-expression levels.
a P value corrected for multiple tests, with use of SNPSpD52 to ﬁnd the effective number of SNPs and with use of Sidak’s method
to ﬁnd the experimentwise error rate with individual SNPs.
table were the analyses involving weighted associations in
which the weighting was based on functionality (Pp
), as well as weighting by association-strength (.00006 Pp
) allele sharing. The LR allele-frequency weighted.00001
measure gave the least signiﬁcant association. Similar re-
sults were found for allele sharing and haplotype sharing,
suggesting that phasing might not aid in detecting asso-
ciations at this locus. Similar results were found with use
of all 26 SNPs versus the subset that excluded the 5 SNPS
not in HWE, although slightly stronger associations were
found with the 21 SNPs in HWE, which suggests thatHWE
could inﬂuence correct calculation of genetic similarity or
that the use of too many SNPs could dilute the association
effect. The ﬁve SNPs that depart from HWE appeared to
have no or little functional consequence. When we re-
stricted analyses to the four tSNPs and calculated genetic
similarity by allele sharing, we found similarly signiﬁcant
results.
Analysis of nonassociated genes and phenotypes.—To show
that our method is not too liberal in identiﬁcation of
associations, we studied two genes, SQSTM1 and GSTM2,
whose expression levels were not correlated with CHI3L2
expression or CHI3L2 polymorphisms. GSTM2 was re-
ported as having signiﬁcant cis-acting SNPs that inﬂuenced
GSTM2-expression levels and is near CHI3L2; SQSTM1 did
not have cis- or trans-acting SNPs that affect its expression
levels. Four SNPs in GSTM2 and 12 SNPs in SQSTM1 were
downloaded from the HapMapWeb site. Two and six SNPs
were excluded from the analyses of GSTM2 and SQSTM1,
respectively, because they were monomorphic. For indi-
vidual SNP analyses with SNPs in SQSTM1 and log2-trans-
formed SQSTM1-expression levels, no SNPs were signiﬁ-
cant ( ). When analyses with genetic similarity byP 1 .15
allele sharing or allele-frequency weighted sharing were
performed, associations did not meet the threshold of
signiﬁcance ( and .3848, respectively) (table 4).Pp .3818
With SNPs in GSTM2 and CHI3L2-expression levels, no
signiﬁcant associations were found with individual SNPs,
allele-sharing similarity, or allele-frequency weighted al-
lele sharing similarity ( ) (table 4).P 1 .38
Assessing Association Signal Strength and Detecting
Interactions
We pursued a few additional studies, to assess the merits
of the proposed analysis procedure. First, we considered
the contribution of each CHI3L2 SNP to the association
strength by removing each SNP from the construction of
the (IBS-based) similarity matrix and rerunning the anal-
ysis with the remaining 25 SNPs. All of the analyses pro-
duced test statistics that were signiﬁcant at the .005 level,
which suggests that no SNP was solely responsible for the
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Table 4. Distance-Based Regression-Analysis Results
Distance Measure Weighted Haplotype
SNPs in HWE All SNPs
Pseudo-F Permuted Pa
Variation
(%) Pseudo-F Permuted Pa
Variation
(%)
CHI3L2 allele sharingb No No 14.35 .00008 20.69 14.85 .00008 21.26
CHI3L2 rare-allele sharingb Allele No 12.30 .00021 18.28 12.08 .00019 18.01
CHI3L2 haplotype sharingb No Yes 16.40 .00007 22.97 14.52 .00008 20.88
CHI3L2 weighted allele sharingb Functional No 14.69 .00006 21.08 14.77 .00007 21.17
CHI3L2 weighted haplotype sharingb Functional Yes 14.80 .00005 21.2 13.46 .00008 19.66
CHI3L2 weighted allele sharingb Conservation No 14.35 .00008 20.69 14.85 .00008 21.26
CHI3L2 weighted haplotype sharingb Conservation Yes 9.78 .00008 15.09 8.87 .00008 13.89
CHI3L2 weighted allele sharingb,d Association strength No 1.12 .00001 15.54
CHI3L2 weighted allele sharingb Association strength No 8.63 .00010 13.57
CHI3L2 allele sharing,b only tSNPs No No 14.91 .00004 21.33
CHI3L2 rare-allele sharing,b only tSNPs Allele No 15.98 .00003 22.51
SQSTM1 allele sharingc No No .8761 .3818 1.57
SQSTM1 rare-allele sharingc Allele No 1.0224 .3848 1.83
GSTM2 allele sharingb No No .6768 .4824 1.22
GSTM2 rare-allele sharingb No No .8794 .4398 1.57
a P value from 100,000 permutations in the similarity-matrix regression analysis.
b Association with averaged, log2 CHI3L2 gene expression levels.
c Association with averaged, log2 SQSTM1 gene expression levels.
d Only signiﬁcant SNPs were used.
Table 5. Effect on the Association
Strength of Omitting Each CHI3L2 SNP
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
association signal, either because of LD relationships be-
tween the SNPs or because of independent functional ef-
fects of the SNPs. To minimize the LD relationships, we
eliminated SNPs ( ) in complete LD ( ) and′np 14 D p 1.0
found a signiﬁcant association (table 5).
Second, we considered the effects of including nonasso-
ciated SNPs in the analysis by assigning individuals’ alleles
via a random-number generator. We constructed IBS-sim-
ilarity matrices with the original CHI3L2 SNPs plus these
nonassociated SNPs. Figure 4 suggests that the original
signal provided by the 26 CHI3L2 SNPs was so strong that
additional SNPs, comprising almost 80% of the SNPs used
to construct the matrix, could not completely eliminate
the statistical signiﬁcance of the association. We note
that the association signal steadily decreased the more we
added nonassociated SNPs, which suggests that associa-
tion strength can be used to identify sets of adjacent SNPs
in a genomic region that inﬂuence phenotypic expression
(ﬁg. 4). Had we conﬁned attention to only the nonasso-
ciated SNPs, no association would have been found. Es-
sentially, the 26 SNPs in the CHI3L2 gene were used ini-
tially to construct the similarity matrix. Additional SNPs
that were randomly assigned to individuals—and hence
were known not to be associated with the phenotype a
priori—were added in greater numbers to those used to
construct the similarity matrix. These matrices were then
analyzed for association.
Third, we considered the analysis of simulated data gen-
erated in a few highly contrived settings involving inter-
acting loci. We considered two biallelic polymorphic sites
in a gene with alleles 0 and 1, for which the combination
of alleles 0 and 0 at the two loci on a chromosome or the
combination 1 and 1 (denoted as “0-0” and “1-1,” respec-
tively) raised the value of a phenotype by a value a. Com-
binations 0-1 and 1-0 decreased phenotype levels by a.
We assumed that the 0 and 1 alleles at each locus were
equally frequent. Note that the mean phenotype value of
an allele at each locus would be 0.0. We then assumed
ﬁve pairs of such interacting loci on a chromosome, for
a total of 10 loci. We then randomly assigned 300 simu-
lated individuals’ alleles at the 10 loci on two chromo-
somes and derived their phenotype value by summing the
appropriate 2-locus values over the 5 locus pairs.We added
noise to their phenotype by generating a standard normal
deviate and adding it to an individual’s phenotype value.
We considered a values of 0.5 (setting 1), 1.0 (setting 2),
and 2.0 (setting 3). Note that single-locus analyses should
not ﬁnd associations with the phenotype in this setting,
and, since we did not assume LD and there are 1,024 (i.e.,
210) equally frequent possible haplotypes across the 10 loci,
haplotype analyses that are based on phylogeny infor-
mation or very extensive and somewhat arbitrary group-
ings are not likely to work. We subjected the simulated
data (available on request) to standard single-locus anal-
yses and the proposed similarity analysis based on IBS
similarity. Standard single-locus analyses identiﬁed no sig-
niﬁcant results (table 6), whereas the similarity analysis
produced P values of .029, .004, and .0024 for settings 1,
2, and 3, respectively.
Discussion
Genetic-association studies have been plaguedwith incon-
sistent results, so questions have been raised about phe-
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Figure 4. The effect of including known nonassociated SNPs in
the construction of the similarity matrix (IBS-similarity measure
used).
Table 6. Standard Regression Analysis–
Based Single-Locus Results Involving the
Data Generated with Interacting Loci
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
nomena thatmay contribute to these inconsistent results.1
Of the many factors that could create problems for large-
scale genomewide association studies, those that concern
data analysis are receiving a great deal of attention. An-
alytic methods are particularly difﬁcult to assess and com-
pare, since there are really no standards for judging them,
given the many settings in which sequence variations can
inﬂuence a phenotype. Thus, somemethodsmay be better
suited to one or a few of these settings than are others.
The most basic approach to the analysis of sequence var-
iation in association studies is to test each individual lo-
cus—independent of the other loci—for association with
the trait or disease in question. This assumes that the ef-
fects of each locus, both within and across the genes stud-
ied, on phenotypic expression are independent. Although
there is some research that considers the analysis of in-
teractions both between and/or across different genes for
association studies,54 there is little research that considers
the simultaneous effect of multiple variations within a
gene. Thus, an alternative or complementary analysis ap-
proach for genetic associations would involve consider-
ation of the actual composition of genes (i.e., consideration
of the effects of particular combinations of variations in
a gene that an individual possesses) and the impact that
these multiple variations have on phenotypic expression.
With this in mind, it is arguable that taking the more
holistic view of genetic variation from a diplotype per-
spective may be appropriate. In addition, it is also arguable
that future association studies should take advantage of
strategies that exploit available biological knowledge about
the functions of genes. Our proposed analysis strategy en-
compasses single-locus– and haplotype-phylogeny–based
approaches to genetic association analyses, but it is much
more ﬂexible and has a number of advantages.
Advantages and Extensions of the Proposed Analysis
Approach
The proposed association-analysis approach hasmany fea-
tures that make it a good complement to existing analysis
methods: it can accommodate many of the biological phe-
nomena known to arise in human gene-phenotype rela-
tionships (e.g., humans are diploid, sequence variations
do not work in isolation, etc.), it exploits the growing
amount of information on sequence variations and their
functional effects, it can be complemented with graphic
aids to assist in interpretation of the data, and, unlike other
association-analysis methods based on the assessment of
similarity, it does not require cluster analysis.
In addition, one of the best features of the proposed
method is its ﬂexibility. The formulation of the test sta-
tistic can admit a wide range of analysis scenarios beyond
analyses that focus on a single gene. For example, we are
exploring the use of our procedure in the assessment of
multiple genomic regions, using pathway information (au-
thors’ unpublished data; M. Zapala and N. J. Schork, un-
published data), the analysis of genome-scan data (J. Wes-
sel, N.Malo, O. Libiger, andN. J. Schork, unpublisheddata),
the analysis ofmultiple phenotypes (authors’ unpublished
data; N. J. Schork, J. Wessel, R. Salem, and D. T. O’Connor,
unpublished data), and the analysis of genetic background
(C. Nievergelt and N. J. Schork, unpublished data; M. Za-
pala and N. J. Schork, unpublished data). The procedure
can also be used for the analysis of other data-analysis
settings (e.g., the analysis of ecological data and gene ex-
pression data44,50) (M. Zapala and N.J.S., unpublished data).
Limitations of the Analysis Approach
There are a few limitations inherent in the proposed mul-
tilocus association–analysis approach. For example, pre-
dicting in vivo functional effects from in vitro studies can
be problematic and, as such, may not provide appropriate
weights for use in the construction of the similarity ma-
trix. The same could be said of the use of model systems
for providing insight into the physiologic effect of genom-
ic variations in humans. In addition, the number of loci
to include in the similarity calculations will not neces-
sarily be known a priori, which is important if relevant
SNPs are left out of the analysis or if too many irrelevant
SNPs are used, which is a general problem with associa-
tion-analysis methods and is not unique to the proposed
approach. The interpretation of the conserved sequence
surrounding SNPs can also be problematic. Many com-
putational approaches to assessing conservation are lim-
ited simply by the available sequence information and the
ability to align sequences from different species. Although
the procedure critically depends on the choice of a simi-
larity measure, this aspect of the procedure makes it ap-
pealing, since modeling the effects of genetic variations
and comparing genomes can be pursued in a variety of
ways, some of which may be more powerful in certain
settings than in others. The power of the proposed ap-
proach in different analysis settings and locus-effect sce-
narios deserves attention, but, since our procedure is
rooted in traditional ANOVA and regression modeling,
many of the same intuitions and ﬁndings related to the
power of these modeling procedures apply. For example,
the proposed procedure assesses the question of howmuch
of the variation in the similarity/dissimilarity exhibited
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by a group of individuals can be explained by another
factor, which is analogous to questions concerning how
much of the variation in a particular trait is explained by
a certain factor in regression and ANOVA power-assess-
ment contexts (authors’ unpublished data).
Another issue with the proposed approach, which is an
issue with all association-analysismethodologies, involves
missing genotype data. One can handle missing genotype
data in a number of ways. First, one could restrict the
construction of the similarity measure to only those in-
dividuals with complete data—which may result in a sub-
stantially reduced sample size—or could simply construct
the measure with the data that are available for each pair
of subjects. This latter approach will be problematic if a
number of individuals are missing genotype data at the
most heavily weighted (i.e., functional) loci. Another ap-
proach to handling missing data would involve imputing
or assigning individuals’ genotype data on the basis of LD
information. This approach would be only as useful as the
strength of the LD between alleles at the loci with missing
data and those with no missing data. The approach we
took to handling missing data was to use whatever geno-
type information was available on the subjects for the
similarity calculations. Since we had very little missing
information (∼1% of all genotype data was missing in the
data set we used), we felt this approach was warranted.
A ﬁnal issue of concern for association studies involves
the effect of stratiﬁcation or genetic-background hetero-
geneity. Our proposed association-analysis approach, like
others, can accommodate such phenomena by simply in-
cluding relevant covariates in the analysis (e.g., race, ge-
netic background–cluster membership, degree of admix-
ture, etc.) that reﬂect genetic-background information for
the subjects in the study.
Despite limitations of the approach—which have less
to do with the mechanics behind the approach and more
to do with deﬁciencies in the available knowledge it tries
to exploit—it is intuitive and ﬂexible and can provide a
complementary approach to existing methods for assess-
ingmultilocus data. The proposed approach is likely tohave
greater applicability and utility in a time when efﬁcient
and cost-effective sequencing technologies can be used to
assess many individuals’ genomes, since one can examine
the similarity of these individuals’ actual DNA sequences
rather than examining commonality of sequence varia-
tions at a few well-chosen sites.
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Web Resources
The accession number and URLs for data presented herein are
as follows:
ESEﬁnder, http://rulai.cshl.edu/tools/ESE/
Gene Expression Omnibus, http://www.ncbi.nlm.nih.gov/geo/(for
baseline expression levels of genes in CEPH individuals from the
International HapMap Project [accession number GSE2552])
Gene Regulation, http://www.gene-regulation.com/pub/programs
.html#pmatch (for P-Match)
GeneTree, http://taxonomy.zoology.gla.ac.uk/rod/genetree/
genetree.html
HapMap, http://www.hapmap.org/
ITB Blast, http://www.ba.itb.cnr.it/BIG/Blast/BlastUTR.html (for
BigBlast)
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi
.nlm.nih.gov/Omim/ (for CHI3L2)
PipMaker and MultiPipMaker, http://pipmaker.bx.psu.edu/
pipmaker/
PolyPhen, http://www.bork.embl-heidelberg.de/PolyPhen/
PupasView, http://pupasview.bioinfo.ochoa.ﬁb.es/
RESCUE-ESE, http://genes.mit.edu/burgelab/rescue-ese/
SIFT, http://blocks.fhcrc.org/sift/SIFT.html
UTRScan, http://www.ba.itb.cnr.it/BIG/UTRScan/
VISTA Genome Browser, http://pipeline.lbl.gov/cgi-bin/gateway2
Vista Tools, http://genome.lbl.gov/vista/index.shtml (for rVISTA)
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